
NanoSyrinx
@nanosyrinx
Engineering biological 'nano-syringes' for next generation drug delivery applications.
ID: 1019914990952878080
19-07-2018 12:00:57
97 Tweet
215 Followers
61 Following


Our #AbbVieUKGoldenTicket programme was a collaboration with the Pioneer Group, to support the UK life sciences vision. We are so happy to support our winners NanoSyrinx in their aim to develop ground-breaking technology. Read more about our partnership: bit.ly/3frWEGu

Some bacteria produce tiny syringes to deliver protein into cells, making these #nanosyringes an exciting new tool for protein #DrugDelivery. Stephanie DeMarco, PhD talked to Nick Shikuma San Diego State University, Charles Ericson ETH Zürich, & NanoSyrinx to learn more. #NationalNanoDay ow.ly/qzBF50L4Nfc

Congratulations to NanoSyrinx for winning the #AbbVieUKGoldenTicket last month👏

Want to hear a great explainer in simple terms about what NanoSyrinx is busy building? Head on over to Spin Up Science Ventures on #youtube to learn all about #drugdelivery using natures own toolkit with #synbio linkedin.com/posts/jrjheale…

Drug delivery progress is moving at a rapid rate. Innovations in the field will prove crucial in shaping the future of biotech. Leading the way is NanoSyrinx, a winner of our Golden Ticket programme. Discover how they harness 'nature's own toolkit' below 👇


Our CEO Joe Healey and CBO James Lapworth are at the 19th Anglonordic today. Feel free to pull us aside for a coffee (or something stronger!) if you'd like to learn more about our upcoming Series A fundraise.

Next week we look forward to joining pioneering 🇬🇧 companies like bit.bio, evonetix, Colorifix, BioIndustry Association (BIA), Basecamp Research, Biome Bioplastics, Yourgene Health, FabricNano, bronic & NanoSyrinx in City of Oakland for SynBioBeta, the largest synthetic biology industry conference.


Our CEO Joe Healey is at SynBioBeta again this year. A bit thank you to the SBB team and Ginkgo Bioworks for awarding us a startup prize to attend for free! Looking forward to catching up with friends new and old! #SynBioBeta2023 #syntheticbiology


📣NEW ARTICLE: 🧬NanoSyrinx 🎱Aim: craft intracellular meds 🔑Key: engineer nano-syringes for versatile precision meds ⏭️Next: target selected diseases (oncology, longevity, metabolic,...) 🎙️Bonus: Dive into their journey, CEO insights & startup advice! buff.ly/3F6oYHW


Future Planet Capital is proud to back five of the companies that have been highlighted in PwC’s Life Sciences Future50 – making up 10% of those selected. Congratulations to Ultromics , ONI , @Synthace, NanoSyrinx and Crescendo Biologics. 👉bit.ly/3QoWFd3 #LifeScience


.NanoSyrinx today announced Anthony Johnson M.D. has joined its Board as Non-Executive Director. Tony’s appointment forms part of NanoSyrinx’ strategy to strengthen the leadership team as it prepares for the next stage in its development. Read more here: rb.gy/zehnsk



.NanoSyrinx today announced the close of a £10M financing round to advance its nanosyringe platform & appointed Dr Edwin Moses as Chairman. Edwin is a high-profile C-level executive with an impressive track record building & scaling biotech companies: rb.gy/ojyk0m


Congratulations to NanoSyrinx after completing a £10 million #financing round!! #NEWS More here: warwick.ac.uk/services/innov…

